Research Article
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Blood to Distinguish Lung Cancer Patients from Healthy Subjects
Table 1
Characteristics of the study participants.
| | Lung cancer group () | Control group () | value | value |
| | Male (%) | 118 (56.2) | 154 (59.0) | 0.377 | 0.539 | | Age (years) | 65 (58-70) | 61 (48-75) | 26077.5 | 0.366 | | WBC (×109/L) | 5.9 (4.7-7.1) | 5.4 (4.7-6.2) | 22420.0 | 0.001 | | HGB (g/L) | 126 (114-136) | 143 (134-154) | 11811.0 | <0.001 | | RDW (%) | 13.0 (12.3-14.1) | 13.4 (13.0-13.9) | 22159.0 | <0.001 | | PDW (fL) | 12.1 (10.5-13.9) | 16.7 (16.4-17.1) | 4478.0 | <0.001 | | NLR | 2.43 (1.67-3.48) | 1.77 (1.39-2.20) | 17290.0 | <0.001 | | PLR | 143.52 (97.46-207.97) | 115.70 (93.50-151.27) | 20680.0 | <0.001 | | AST (U/L) | 22 (18-28) | 23 (20-28) | 22979.5 | 0.003 | | UR (mmol/L) | 5.7 (4.4-6.9) | 5.2 (4.2-6.3) | 24085.5 | 0.024 | | GLU (mmol/L) | 5.39 (4.89-5.94) | 5.59 (5.25-6.31) | 21739.5 | <0.001 |
|
|
Categorical variable; chi-squared test value. Abbreviation: AST: aspartate transaminase; UR: urea; GLU: glucose; WBC: white blood cell; HGB: hemoglobin; RDW: red blood cell distribution width; PDW: platelet distribution width; NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio. |
